Health Canada Approves Remsima™ SC for the Treatment of Inflammatory Bowel Disease (IBD)

Remsima™ SC, the first subcutaneous infliximab, now approved in Canada for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) and Crohn’s disease (CD)1 The approval is based on results from the LIBERTY2,3 studies demonstrating superior efficacy and comparable safety profiles of Remsima™ SC over placebo in patients with IBD The approval [……
Read More

Get A FREE Copy Of My Special Report
“Can Your Retirement Survive” Today!
There's Absolutely $0 Cost To You!
We Even Pay For Shipping & Handling!

This post contains affiliate links. If you use these links to buy something we may earn a commission. Thanks.”

You May Also Like